Chromocell (CHRO) - Market Value

This daily price chart for Chromocell Therapeutics (CHRO) illustrates the price action of an asset with a market capitalization of 0.01. The business focuses on discovering opioid alternatives by developing specific NaV1.7 ion channel blockers. The project relies on external contractors for substance synthesis and testing, while racing for rapid regulatory approval to outperform competitors in the pain management segment.

CHRO Chromocell Therapeutics Corp.: Market Value in the range 02/21/2024 - 07/02/2025

CHRO (Chromocell): analytical breakdowns and indicator data

- current price and projected stock value:

Stock Price Chromocell Therapeutics Corp.|CHRO - Fair Value Consensus

- market capitalization indicators:

Market Value Chromocell|CHRO - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share Chromocell Therapeutics|CHRO - Total Stockholders' Equity|Market Value to Book Value Ratio chromocell.com|CHRO - Total Business Assets

- debt and solvency information:

Total Debt to Capital Chromocell Therapeutics|CHRO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Chromocell Therapeutics|CHRO - Company Aggregate Debts|Debt to Book Capitalization Ratio Chromocell|CHRO - Company Long-Term Loans and Borrowings|Company Short-Term Debt Chromocell Therapeutics|Quick Ratio chromocell.com

- business earnings and investment ratios data:

CHRO - Net Income|Projected Future Earnings Chromocell Therapeutics|CHRO - Company Value to Net Income|Future Price to Earnings Chromocell Therapeutics Corporation|CHRO - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Chromocell|CHRO - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Chromocell Therapeutics|CHRO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months chromocell.com|CHRO - Earnings per share growth rate in current year|Earnings growth forecast for next year Chromocell Therapeutics

Fundamental company analysis:CHRO (Chromocell Therapeutics Corp.)

The development of ion channel research at Chromocell Therapeutics (CHRO) is directly reflected in the dynamics of the company's market capitalization. This indicator is calculated as the product of the current share price and the total number of outstanding securities. It captures the aggregate value of the business, excluding short-term market noise. For a biotech firm, growth in this metric confirms the value of intellectual assets for future licensing deals. It is critical for investors to distinguish fundamental growth from speculative overheating.

Key competitors